(NYSE:GMED), NEW YORK, May 28, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Globus Medical, Inc. (“Globus” or the “Company”) (NYSE: GMED). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Globus and certain of its officers and/or directors have […]

(NASDAQ:NFE), NEW YORK, May 28, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of New Fortress Energy Inc. (“New Fortress” or the “Company”) (NASDAQ: NFE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether New Fortress and certain of its officers

The Chan Centre for the Performing Arts unveils 2025/2026 season celebrating global excellence The new season comes with international programming and a new membership model prioritizing engagement GlobeNewswire May 28, 2025 VANCOUVER, British Columbia, May 28, 2025 (GLOBE NEWSWIRE) — The Chan Centre for the Performing Arts proudly unveils its bold vision for the 2025/2026

(NASDAQ:META), NEW YORK, May 28, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Meta Platforms, Inc. (“Meta” or the “Company”) (NASDAQ: META). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Meta and certain of its officers and/or directors have

Connect Biopharma to Present at Two Upcoming Investor Conferences in June GlobeNewswire May 28, 2025 SAN DIEGO, May 28, 2025 (GLOBE NEWSWIRE) — Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma” or the “Company”), a clinical-stage biopharmaceutical company focused on transforming acute and chronic care of asthma and chronic obstructive pulmonary disease (COPD), today announced

ASHBURN, Va. and RESTON, Va., May 28, 2025 (GLOBE NEWSWIRE) — Cypher LLC, a leader in advanced analytics and artificial intelligence, and Carahsoft Technology Corp., The Trusted Government IT Solutions Provider(R), today announced a partnership. Under the agreement, Carahsoft will serve as Cypher's Master Government Aggregator(R), expanding Public Sector access to Cypher's powerful G.H.O.S.T. platform

(NASDAQ:SDGR), NEW YORK, May 28, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Schrodinger, Inc. (“Schrodinger” or the “Company”) (NASDAQ: SDGR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Schrodinger and certain of its officers and/or directors have engaged

Immunotherapeutic Targets for Recurrent Medulloblastoma Receives $85K Grant from Brain Cancer Canada GlobeNewswire May 28, 2025 TORONTO, May 28, 2025 (GLOBE NEWSWIRE) — Brain Cancer Canada is proud to award $85,000 to a groundbreaking research project led by Dr. Sheila Singh and her team at McMaster University. The project titled “Lamin B Receptor (LBR) as

(NasdaqGM:FLGT), NEW YORK, May 28, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Fulgent Genetics, Inc. (“Fulgent” or the “Company”) (NASDAQ: FLGT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Fulgent and certain of its officers and/or directors have

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Humana Inc. – HUM GlobeNewswire May 28, 2025 NEW YORK, May 28, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Humana Inc. (“Humana” or the “Company”) (NYSE: HUM). Such investors are advised to contact Danielle Peyton at